vs

Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and Chatham Lodging Trust (CLDT). Click either name above to swap in a different company.

BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $67.7M, roughly 1.2× Chatham Lodging Trust). BillionToOne, Inc. runs the higher net margin — 6.8% vs 6.8%, a 0.0% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs -9.8%).

BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.

Chatham Lodging Trust is a publicly traded real estate investment trust that invests in, owns, and operates upscale extended-stay and select-service premium hotel properties primarily across high-demand urban and suburban markets in the United States. Its portfolio targets assets with strong occupancy rates and steady cash flow from business and leisure traveler segments.

BLLN vs CLDT — Head-to-Head

Bigger by revenue
BLLN
BLLN
1.2× larger
BLLN
$83.5M
$67.7M
CLDT
Growing faster (revenue YoY)
BLLN
BLLN
+127.2% gap
BLLN
117.4%
-9.8%
CLDT
Higher net margin
BLLN
BLLN
0.0% more per $
BLLN
6.8%
6.8%
CLDT

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BLLN
BLLN
CLDT
CLDT
Revenue
$83.5M
$67.7M
Net Profit
$5.7M
$4.6M
Gross Margin
69.9%
Operating Margin
11.5%
15.9%
Net Margin
6.8%
6.8%
Revenue YoY
117.4%
-9.8%
Net Profit YoY
138.3%
369.9%
EPS (diluted)
$0.10
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLLN
BLLN
CLDT
CLDT
Q4 25
$67.7M
Q3 25
$83.5M
$78.4M
Q2 25
$80.3M
Q1 25
$68.6M
Q4 24
$75.1M
Q3 24
$38.4M
$87.2M
Q2 24
$86.5M
Q1 24
$68.4M
Net Profit
BLLN
BLLN
CLDT
CLDT
Q4 25
$4.6M
Q3 25
$5.7M
$3.5M
Q2 25
$5.4M
Q1 25
$1.5M
Q4 24
$-1.7M
Q3 24
$-14.9M
$4.3M
Q2 24
$6.8M
Q1 24
$-5.2M
Gross Margin
BLLN
BLLN
CLDT
CLDT
Q4 25
Q3 25
69.9%
Q2 25
Q1 25
Q4 24
40.7%
Q3 24
52.6%
44.7%
Q2 24
46.1%
Q1 24
38.9%
Operating Margin
BLLN
BLLN
CLDT
CLDT
Q4 25
15.9%
Q3 25
11.5%
12.7%
Q2 25
14.8%
Q1 25
12.1%
Q4 24
7.5%
Q3 24
-32.9%
14.3%
Q2 24
16.3%
Q1 24
1.4%
Net Margin
BLLN
BLLN
CLDT
CLDT
Q4 25
6.8%
Q3 25
6.8%
4.5%
Q2 25
6.7%
Q1 25
2.2%
Q4 24
-2.3%
Q3 24
-38.8%
4.9%
Q2 24
7.9%
Q1 24
-7.6%
EPS (diluted)
BLLN
BLLN
CLDT
CLDT
Q4 25
$0.05
Q3 25
$0.10
$0.03
Q2 25
$0.07
Q1 25
$-0.01
Q4 24
$-0.08
Q3 24
$-1.47
$0.05
Q2 24
$0.10
Q1 24
$-0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLLN
BLLN
CLDT
CLDT
Cash + ST InvestmentsLiquidity on hand
$195.2M
$24.4M
Total DebtLower is stronger
$55.0M
$338.9M
Stockholders' EquityBook value
$-239.5M
$740.8M
Total Assets
$327.5M
$1.2B
Debt / EquityLower = less leverage
0.46×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLLN
BLLN
CLDT
CLDT
Q4 25
$24.4M
Q3 25
$195.2M
$13.2M
Q2 25
$17.2M
Q1 25
$18.6M
Q4 24
$20.2M
Q3 24
$19.3M
Q2 24
$10.6M
Q1 24
$72.3M
Total Debt
BLLN
BLLN
CLDT
CLDT
Q4 25
$338.9M
Q3 25
$55.0M
$338.8M
Q2 25
$351.2M
Q1 25
$381.1M
Q4 24
$406.9M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BLLN
BLLN
CLDT
CLDT
Q4 25
$740.8M
Q3 25
$-239.5M
$749.4M
Q2 25
$754.1M
Q1 25
$754.7M
Q4 24
$758.2M
Q3 24
$-242.9M
$765.3M
Q2 24
$766.5M
Q1 24
$765.0M
Total Assets
BLLN
BLLN
CLDT
CLDT
Q4 25
$1.2B
Q3 25
$327.5M
$1.2B
Q2 25
$1.2B
Q1 25
$1.2B
Q4 24
$1.3B
Q3 24
$1.3B
Q2 24
$1.3B
Q1 24
$1.3B
Debt / Equity
BLLN
BLLN
CLDT
CLDT
Q4 25
0.46×
Q3 25
0.45×
Q2 25
0.47×
Q1 25
0.50×
Q4 24
0.54×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLLN
BLLN
CLDT
CLDT
Operating Cash FlowLast quarter
$13.8M
$64.1M
Free Cash FlowOCF − Capex
$6.5M
FCF MarginFCF / Revenue
7.7%
Capex IntensityCapex / Revenue
8.8%
Cash ConversionOCF / Net Profit
2.42×
13.90×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLLN
BLLN
CLDT
CLDT
Q4 25
$64.1M
Q3 25
$13.8M
$25.6M
Q2 25
$22.1M
Q1 25
$4.2M
Q4 24
$73.8M
Q3 24
$28.8M
Q2 24
$25.2M
Q1 24
$6.9M
Free Cash Flow
BLLN
BLLN
CLDT
CLDT
Q4 25
Q3 25
$6.5M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
BLLN
BLLN
CLDT
CLDT
Q4 25
Q3 25
7.7%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
BLLN
BLLN
CLDT
CLDT
Q4 25
Q3 25
8.8%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Cash Conversion
BLLN
BLLN
CLDT
CLDT
Q4 25
13.90×
Q3 25
2.42×
7.24×
Q2 25
4.10×
Q1 25
2.73×
Q4 24
Q3 24
6.78×
Q2 24
3.68×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BLLN
BLLN

Prenatal$74.1M89%
Oncology$8.7M10%

CLDT
CLDT

Occupancy$61.5M91%
Hotel Other$4.2M6%
Food And Beverage$1.8M3%
Hotel$1.1M2%

Related Comparisons